.jpeg)
2026-03-24 04:27:54
Pegcetacoplan is a complement C3 inhibitor for paroxysmal nocturnal hemoglobinuria (PNH) treatment. This article details injection reactions, infection risks and monitoring points to help patients use medication safely.
2026-03-24 04:11:29
Cabotegravir Sodium (Vocabria) is an HIV integrase inhibitor for HIV-1 infection treatment and PrEP. This article details headache, liver injury, allergic reactions and monitoring points to help patients use medication safely.
2026-03-24 03:56:40
Vericiguat (Verquvo) is an sGC stimulator for chronic heart failure treatment. This article details hypotension, anemia, gastrointestinal reactions and monitoring points to help patients use medication safely.
2026-03-20 03:27:09
Clonal hematopoiesis of indeterminate potential refers to somatic mutations in hematopoietic stem cells, associated with tumor development, with standardized research holding important value for precision medicine.
2026-03-20 03:20:58
Pegcetacoplan is a PEGylated complement C3 inhibitor used for treating adult paroxysmal nocturnal hemoglobinuria, providing comprehensive control of complement-mediated hemolytic reactions.
2026-03-20 03:13:56
Cabotegravir sodium is an integrase strand transfer inhibitor used for HIV-1 treatment and pre-exposure prevention, supporting long-acting injection regimens suitable for patients with adherence challenges.
2026-03-19 04:04:05
Eltrombopag is a novel oral TPO receptor agonist that stimulates bone marrow megakaryocytes to promote platelet production, providing non-immunosuppressive treatment options for patients with immune thrombocytopenia and aplastic anemia.
2026-03-18 06:00:53
Latest systematic review study finds that use of tyrosine kinase inhibitors and Janus kinase inhibitors may be associated with increased keratinocyte carcinoma risk, providing important reference for tumor drug therapy safety assessment.
2026-03-18 05:49:30
CLISGen is an innovative database platform integrating SNP genotype information from cancer cell lines, containing genetic data from over 1000 cancer cell lines, helping researchers efficiently select cell models with specific genetic variations and breaking through bottlenecks in tumor functional genomics research.
2026-03-18 05:32:12
Apremilast is an oral small-molecule PDE4 inhibitor used to treat psoriasis, psoriatic arthritis and Behcet's disease. This article explains its mechanism, efficacy and safety.
2026-03-17 07:23:12
Records the complete treatment journey of an ALK-positive non-small cell lung cancer patient using Brigatinib, covering initial medication reactions, side effect management, efficacy evaluation, and lifestyle adjustments, providing real reference for similar patients.
2026-03-17 07:09:35
Brigatinib is a second-generation ALK inhibitor designed for ALK-positive non-small cell lung cancer patients. This article details drug mechanism, indications, side effect management, and latest clinical advances to support scientific medication use.
